Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Bean extract may tame blood sugar spikes after carbs

NCT ID NCT07466667

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 3 times

Summary

This study tests whether a supplement called Phaseolean, made from white kidney beans, can help healthy adults keep their blood sugar steady after eating carb-rich foods like white bread. Twelve participants will take different doses of the supplement or a control before a meal, and their blood sugar and feelings of fullness will be measured. It's an early, small study in healthy people, so any benefits are uncertain and not yet proven for those with diabetes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Phaseolean (White Kidney Bean Extract)
What this could lead to
If it works, this could point toward a natural supplement to help manage blood sugar spikes after meals.
What could go wrong
This is a very small, early trial in healthy people only. Results may not apply to those with diabetes or other conditions, and the supplement may have no real effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Mar 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1)Age: 18 to 45 years (both inclusive) at the time of consent Sex: male and non-pregnant/non-lactating female. 3) Females of childbearing potential must have a negative urine pregnancy test performed on screening visits. 4\) Participants having fasting blood glucose levels less than 100 milligrams per decilitre. 5\) Participants with a Body Mass Index of 18.5 to 25 kilogram per meter square (both inclusive). 6\) Participant is in good general health as determined by the Investigator on the basis of medical history and vital signs. 7\) Participants should be willing and able to follow the study protocol to participate in the study. 8\) Participant must be able to understand and provide written informed consent to participate in the study. 9\) Participant is willing to refrain from vigorous physical exercise during the study period. 10\) Participants is willing to stay overnight as per study specification requirements. Exclusion Criteria: 1. Participant has any known food allergy or intolerance to any food or beverages. 2. Participant is taking any medication in the past one week. 3. Participants should not be taking any medications known to affect glucose tolerance (excluding oral contraceptives) - stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable 4. Participants should not have any known food allergy or intolerance 5. Presence of any chronic disease or illness in the past three months or any clinically significant on-going chronic medical illness e.g. Congestive cardiac failure, Hepatitis, Hypotensive episodes, etc. 6. Recent history of dehydration from diarrhoea, vomiting or any other reason within a period of 24 hours prior to the study. 7. Participation in any similar clinical trial within the past 90 days with blood loss more than 450 millilitre. 8. An unusual diet, special diet, for whatever reason e.g. high protein diet, low sodium diet, for two weeks prior to receiving any test food and throughout the Participant's participation in the study. 9. Participant has performed vigorous physical exercise in the morning on dosing day. 10. Pregnant or lactating females. 11. Self-reported Positive Human Immunodeficiency Virus test. 12. History of Hepatitis B or C virus self-reported

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • NovoBliss Research

    Ahmedabad, Gujarat, 382481, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.